imipramine has been researched along with Autosomal Chromosome Disorders in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shapiro, IuL | 1 |
Vaĭntrub, MIa | 1 |
Grinberg, KN | 1 |
Zhurkov, VS | 1 |
Roth, B | 1 |
Buůhová, S | 1 |
Berková, L | 1 |
1 review available for imipramine and Autosomal Chromosome Disorders
Article | Year |
---|---|
[Teratogenic and mutagenic effects of anticonvulsive and psychotropic drugs (review of the literature)].
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Animals; Anticonvulsants; Antidepressive Agent | 1972 |
1 other study available for imipramine and Autosomal Chromosome Disorders
Article | Year |
---|---|
Familial sleep paralysis.
Topics: Adult; Aged; Chromosome Aberrations; Chromosome Disorders; Female; Follow-Up Studies; Humans; Imipra | 1968 |